Fairmount Funds Management LLC
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1802528
WEST CONSHOHOCKEN, PA
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$76,566,798
-$45,251,134 QoQ
Shares Held
3,914,458
0.0% QoQ
Ownership
3.80%
of shares outstanding
% of Portfolio
5.53%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fairmount Funds Management LLC holds $1,384,339,426 across 12 Biotechnology names. VRDN ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DMRA |
Damora Therapeutics, Inc.
|
8,713,000 | $225,666,700 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
2,537,191 | $212,921,068 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
5,503,418 | $211,826,558 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
4,018,101 | $202,673,014 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
3,705,262 | $181,743,101 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
This page
|
3,914,458 | $76,566,798 | |
| 7 | ELVN |
Enliven Therapeutics, Inc.
|
1,855,644 | $72,741,244 | |
| 8 | JBIO |
Jade Biosciences, Inc.
|
4,553,494 | $63,976,590 |
All Filings in VRDN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-05-11 | $295,870,960 | 17,201,800 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $76,566,798 | 3,914,458 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $121,817,932 | 3,914,458 | Shares | Sole | 2026-02-17 | |
| 2025-10-23 | $353,679,033 | 16,025,330 | Shares | Sole | 2025-10-27 | |
| 2025-09-30 | $74,664,922 | 3,459,913 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $48,369,583 | 3,459,913 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $46,449,559 | 3,445,813 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $66,056,235 | 3,445,813 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $78,392,245 | 3,445,813 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $24,014,027 | 1,845,813 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $32,320,185 | 1,845,813 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,830,388 | 1,369,623 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,010,016 | 1,369,623 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $32,583,331 | 1,369,623 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $34,843,209 | 1,369,623 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,006,687 | 1,369,623 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $28,090,967 | 1,369,623 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $10,923,144 | 944,092 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,456,261 | 944,092 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,664,698 | 944,092 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,530,313 | 944,092 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $641,832 | 35,092 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $586,387 | 35,092 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||